Tamara Vokes
Section of Endocrinology, Diabetes and Metabolism
Professor of Medicine
Medical Director, 150 E. Huron
Referring Physician Access Line: 1-877-DOM-2730


MD1977University of Belgrade 
Residency1982Ravenswood HospitalInternal Medicine
Fellowship1983University of CaliforniaEndocrinology
Fellowship1985The University of ChicagoEndocrinology

Academic Interests

Dr. Vokes’ investigations focus on two areas. One is to examine the clinical application of non-invasive assessment of bone structure and radiographic texture to the field of osteoporosis. Dr. Vokes is examining how computerized texture analysis of digitized high-resolution images of trabecular bone improves our ability to diagnose bone fragility and follow natural history and/or response to pharmacologic therapy of osteoporosis. The second area of interest is to describe the clinical features, and search for genetic and molecular defects underlying fragility in patients who have low trauma fractures but do not have osteoporosis by bone mineral density criteria.

Clinical Interests

Osteoporosis and metabolic bone diseases

Representative Publications

  1. Vokes, T., Lauderdale, D., Ma, S.L., Chinander, M., Childs, K., Giger, M.:Radiographic Texture Analysis of Densitometric Calcaneal Images - Relationship to Clinical Characteristics and to Bone Fragility. 2010 J Bone Miner Res. Jan;25(1):56-63. PMID: 19594292
  2. Vokes, T.J., Gilen, D.: Using clinical risk factors and bone mineral density to determine who among patients undergoing bone densitometry should have Vertebral Fracture Assessment (VFA). 2010 Osteoporos Int. 21 (12): 2083-2091 PMID: 20306020
  3. Lansdown, D., Bennet, B., Thiel, S., Ahmed, O., Dixon, L., Vokes, T.J.: Prevalence of vertebral fractures on chest radiographs of elderly African American and Caucasian women. Osteoporos Int., in press, PMID: 21060991
  4. Mannstadt, M., Clarke, B., Vokes, T., Brandi, M.L., Ranganath, L., Fraser, W.D., Lakatos, P., Bajnok, L., Garceau, R., Mosekilde, L., Lagast, H., Shoback, D., Bilezikian, J.P.: Efficacy and Safety of Recombinant Human Parathyroid Hormone (1-84) in Hypoparathyroidism (REPLACE: a double-blind placebo-controlled, randomized phase 3 study. The Lancet Diabetes & Endocrinology, 1 (4): 275 - 283, December 2013, doi:10.1016/S2213-8587(13)70106-2, epub 07 October 2013
  5. Chou, S., Vokes, T., Ma, S., Costelo, M., Rosen. H. and Schousboe, J: Simplified criteria for selecting patients for vertebral fracture assessment (VFA). Journal of Clinical Densitometry.J Clin Densitom. 2014 Jul-Sep;17(3):386-91. doi: 10.1016/j.jocd.2013.11.003. Epub 2014 Feb 25.

More Information

For more information about Dr. Tamara Vokes publications and research collaborations , please click here